Literature DB >> 22781094

When access is an issue: exploring barriers to predictive testing for Huntington disease in British Columbia, Canada.

Alice K Hawkins1, Susan Creighton, Michael R Hayden.   

Abstract

Predictive testing (PT) for Huntington disease (HD) requires several in-person appointments. This requirement may be a barrier to testing so that at risk individuals do not realize the potential benefits of PT. To understand the obstacles to PT in terms of the accessibility of services, as well as exploring mechanisms by which this issue may be addressed, we conducted an interview study of individuals at risk for HD throughout British Columbia, Canada. Results reveal that the accessibility of PT can be a barrier for two major reasons: distance and the inflexibility of the testing process. Distance is a structural barrier, and relates to the time and travel required to access PT, the financial and other opportunity costs associated with taking time away from work and family to attend appointments and the stress of navigating urban centers. The inflexibility of the testing process barrier relates to the emotional and psychological accessibility of PT. The results of the interview study reveal that there are access barriers to PT that deter individuals from receiving the support, information and counseling they require. What makes accessibility of PT services important is not just that it may result in differences in quality of life and care, but because these differences may be addressed with creative and adaptable solutions in the delivery of genetic services. The study findings underscore the need for us to rethink and personalize the way we deliver such services to improve access issues to prevent inequities in the health care system.

Entities:  

Mesh:

Year:  2012        PMID: 22781094      PMCID: PMC3548262          DOI: 10.1038/ejhg.2012.147

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  29 in total

1.  Predictive testing for Huntington's disease: the calm after the storm.

Authors:  M R Hayden
Journal:  Lancet       Date:  2000-12-09       Impact factor: 79.321

2.  Pitfalls in counseling for predictive testing in Huntington disease.

Authors:  K Demyttenaere; G Evers-Kiebooms; M Decruyenaere
Journal:  Birth Defects Orig Artic Ser       Date:  1992

3.  A vision for the future of genomics research.

Authors:  Francis S Collins; Eric D Green; Alan E Guttmacher; Mark S Guyer
Journal:  Nature       Date:  2003-04-14       Impact factor: 49.962

Review 4.  Genetic testing for hereditary cancer: challenges to ethical care in rural and remote communities.

Authors:  Lori D'Agincourt-Canning
Journal:  HEC Forum       Date:  2004-12

Review 5.  Huntington's disease.

Authors:  Francis O Walker
Journal:  Lancet       Date:  2007-01-20       Impact factor: 79.321

6.  Telegenetic medicine: improved access to services in an underserved area.

Authors:  H J Stalker; R Wilson; H McCune; J Gonzalez; M Moffett; R T Zori
Journal:  J Telemed Telecare       Date:  2006       Impact factor: 6.184

7.  An assessment of the efficacy of cancer genetic counselling using real-time videoconferencing technology (telemedicine) compared to face-to-face consultations.

Authors:  Jordanna Joaquina Coelho; Angela Arnold; Jeremy Nayler; Marc Tischkowitz; James MacKay
Journal:  Eur J Cancer       Date:  2005-10       Impact factor: 9.162

8.  Telemedicine and clinical genetics: establishing a successful service.

Authors:  M R Gattas; J C MacMillan; I Meinecke; M Loane; R Wootton
Journal:  J Telemed Telecare       Date:  2001       Impact factor: 6.184

9.  Predictive, pre-natal and diagnostic genetic testing for Huntington's disease: the experience in Canada from 1987 to 2000.

Authors:  S Creighton; E W Almqvist; D MacGregor; B Fernandez; H Hogg; J Beis; J P Welch; C Riddell; R Lokkesmoe; M Khalifa; J MacKenzie; A Sajoo; S Farrell; F Robert; A Shugar; A Summers; W Meschino; D Allingham-Hawkins; T Chiu; A Hunter; J Allanson; H Hare; J Schween; L Collins; S Sanders; C Greenberg; S Cardwell; E Lemire; P MacLeod; M R Hayden
Journal:  Clin Genet       Date:  2003-06       Impact factor: 4.438

10.  The psychological consequences of predictive testing for Huntington's disease. Canadian Collaborative Study of Predictive Testing.

Authors:  S Wiggins; P Whyte; M Huggins; S Adam; J Theilmann; M Bloch; S B Sheps; M T Schechter; M R Hayden
Journal:  N Engl J Med       Date:  1992-11-12       Impact factor: 91.245

View more
  10 in total

1.  22 Years of predictive testing for Huntington's disease: the experience of the UK Huntington's Prediction Consortium.

Authors:  Sheharyar S Baig; Mark Strong; Elisabeth Rosser; Nicola V Taverner; Ruth Glew; Zosia Miedzybrodzka; Angus Clarke; David Craufurd; Oliver W Quarrell
Journal:  Eur J Hum Genet       Date:  2016-05-11       Impact factor: 4.246

2.  Experiences of Genetic Counselors Practicing in Rural Areas.

Authors:  Margaret Emmet; Quinn Stein; Erin Thorpe; MaryAnn Campion
Journal:  J Genet Couns       Date:  2017-08-22       Impact factor: 2.537

3.  Prenatal testing in Huntington disease: after the test, choices recommence.

Authors:  Hanane Bouchghoul; Stéphane-Françoise Clément; Danièle Vauthier; Cécile Cazeneuve; Sandrine Noel; Marc Dommergues; Delphine Héron; Jacky Nizard; Marcela Gargiulo; Alexandra Durr
Journal:  Eur J Hum Genet       Date:  2016-06-15       Impact factor: 4.246

4.  Access to personalized medicine: factors influencing the use and value of gene expression profiling in breast cancer treatment.

Authors:  Y Bombard; L Rozmovits; M Trudeau; N B Leighl; K Deal; D A Marshall
Journal:  Curr Oncol       Date:  2014-06       Impact factor: 3.677

5.  Perspectives on Genetic Testing and Return of Results from the First Cohort of Presymptomatically Tested Individuals At Risk of Huntington Disease.

Authors:  K M Stuttgen; J M Bollinger; R L Dvoskin; A McCague; B Shpritz; J Brandt; Debra J H Mathews
Journal:  J Genet Couns       Date:  2018-07-02       Impact factor: 2.537

Review 6.  A systematic review of geographical inequities for accessing clinical genomic and genetic services for non-cancer related rare disease.

Authors:  Stephanie Best; Nada Vidic; Kim An; Felicity Collins; Susan M White
Journal:  Eur J Hum Genet       Date:  2022-01-20       Impact factor: 5.351

7.  Access to Specialist Care in Rural Saskatchewan: The Saskatchewan Rural Health Study.

Authors:  Chandima P Karunanayake; Donna C Rennie; Louise Hagel; Joshua Lawson; Bonnie Janzen; William Pickett; James A Dosman; Punam Pahwa
Journal:  Healthcare (Basel)       Date:  2015-02-16

Review 8.  Genetic counseling and testing practices for late-onset neurodegenerative disease: a systematic review.

Authors:  Ashley Crook; Chris Jacobs; Toby Newton-John; Rosie O'Shea; Alison McEwen
Journal:  J Neurol       Date:  2021-03-01       Impact factor: 6.682

9.  Far and wide: Exploring provider utilization of remote service provision for genome-wide sequencing in Canada.

Authors:  Emily A Enns; Tasha Wainstein; Nick Dragojlovic; Nicola Kopac; Larry D Lynd; Alison M Elliott
Journal:  Mol Genet Genomic Med       Date:  2021-09-17       Impact factor: 2.183

10.  Knowledge of genetic testing for hereditary kidney cancer in Canada is lacking: The results of the Canadian national hereditary kidney cancer needs assessment survey.

Authors:  Philippe D Violette; Suzanne Kamel-Reid; Gail E Graham; M Neil Reaume; Michael A Jewett; Melanie Care; Joan Basiuk; Stephen E Pautler
Journal:  Can Urol Assoc J       Date:  2014-11       Impact factor: 1.862

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.